Literature DB >> 18614541

Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity.

Roderik M Kortlever1, Jeroen H Nijwening, René Bernards.   

Abstract

The cytokine transforming growth factor beta (TGFbeta) has strong antiproliferative activity in most normal cells but contributes to tumor progression in the later stages of oncogenesis. It is not fully understood which TGFbeta target genes are causally involved in mediating its cytostatic activity. We report here that suppression of the TGFbeta target gene encoding plasminogen activator inhibitor-1 (PAI-1) by RNA interference leads to escape from the cytostatic activity of TGFbeta both in human keratinocytes (HaCaTs) and primary mouse embryo fibroblasts. Consistent with this, PAI-1 knock-out mouse embryo fibroblasts are also resistant to TGFbeta growth arrest. Conversely, we show that ectopic expression of PAI-1 in proliferating HaCaT cells induces a growth arrest. PAI-1 knockdown does not interfere with canonical TGFbeta signaling as judged by SMAD phosphorylation and induction of bona fide TGFbeta target genes. Instead, knockdown of PAI-1 results in sustained activation of protein kinase B. Significantly, we find that constitutive protein kinase B activity leads to evasion of the growth-inhibitory action of TGFbeta. Our data are consistent with a model in which induction of PAI-1 by TGFbeta is critical for the induction of proliferation arrest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614541      PMCID: PMC3259838          DOI: 10.1074/jbc.M803341200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Differentiation plasticity regulated by TGF-beta family proteins in development and disease.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

Review 2.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

Review 3.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

Review 4.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.

Authors:  Roderik M Kortlever; Paul J Higgins; René Bernards
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

6.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.

Authors:  Incheol Shin; F Michael Yakes; Federico Rojo; Nah-Young Shin; Andrei V Bakin; Jose Baselga; Carlos L Arteaga
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

7.  Stable suppression of tumorigenicity by virus-mediated RNA interference.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

8.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.

Authors:  Jiyong Liang; Judit Zubovitz; Teresa Petrocelli; Rouslan Kotchetkov; Michael K Connor; Kathy Han; Jin-Hwa Lee; Sandra Ciarallo; Charles Catzavelos; Richard Beniston; Edmee Franssen; Joyce M Slingerland
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

9.  Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.

Authors:  Giuseppe Viglietto; Maria Letizia Motti; Paola Bruni; Rosa Marina Melillo; Amelia D'Alessio; Daniela Califano; Floriana Vinci; Gennaro Chiappetta; Philip Tsichlis; Alfonso Bellacosa; Alfredo Fusco; Massimo Santoro
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

Review 10.  A delicate balance: TGF-beta and the tumor microenvironment.

Authors:  Daniel G Stover; Brian Bierie; Harold L Moses
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

View more
  28 in total

1.  Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.

Authors:  Rohan Samarakoon; Sevann Helo; Amy D Dobberfuhl; Nidah S Khakoo; Lucas Falke; Jessica M Overstreet; Roel Goldschmeding; Paul J Higgins
Journal:  J Pathol       Date:  2015-04-27       Impact factor: 7.996

2.  Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβ.

Authors:  Myra L Wang; Ryan Walsh; Kristin L Robinson; Julja Burchard; Steven R Bartz; Michele Cleary; Denise A Galloway; Carla Grandori
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  The basic helix-loop-helix/leucine zipper transcription factor USF2 integrates serum-induced PAI-1 expression and keratinocyte growth.

Authors:  Li Qi; Craig E Higgins; Stephen P Higgins; Brian K Law; Tessa M Simone; Paul J Higgins
Journal:  J Cell Biochem       Date:  2014-10       Impact factor: 4.429

4.  Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses.

Authors:  Jessica M Overstreet; Rohan Samarakoon; Diana Cardona-Grau; Roel Goldschmeding; Paul J Higgins
Journal:  FASEB J       Date:  2014-12-05       Impact factor: 5.191

5.  4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation.

Authors:  Rania Azar; Amandine Alard; Christiane Susini; Corinne Bousquet; Stéphane Pyronnet
Journal:  EMBO J       Date:  2009-10-15       Impact factor: 11.598

6.  PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; J Andrew Carlson; Agnes Noel; Jean-Michel Foidart; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Oncol       Date:  2010-03-01       Impact factor: 4.375

7.  Requirement of a dynein light chain in TGFbeta/Smad3 signaling.

Authors:  Qunyan Jin; Guofeng Gao; Kathleen M Mulder
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

Review 8.  Senescence-messaging secretome: SMS-ing cellular stress.

Authors:  Thomas Kuilman; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2009-01-09       Impact factor: 60.716

9.  SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin.

Authors:  Wenteh Chang; Ke Wei; Susan S Jacobs; Daya Upadhyay; David Weill; Glenn D Rosen
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

10.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.

Authors:  Sara I Cunha; Evangelia Pardali; Midory Thorikay; Charlotte Anderberg; Lukas Hawinkels; Marie-José Goumans; Jasbir Seehra; Carl-Henrik Heldin; Peter ten Dijke; Kristian Pietras
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.